JP2008520669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520669A5 JP2008520669A5 JP2007543135A JP2007543135A JP2008520669A5 JP 2008520669 A5 JP2008520669 A5 JP 2008520669A5 JP 2007543135 A JP2007543135 A JP 2007543135A JP 2007543135 A JP2007543135 A JP 2007543135A JP 2008520669 A5 JP2008520669 A5 JP 2008520669A5
- Authority
- JP
- Japan
- Prior art keywords
- iron chelator
- human
- inflammation
- iron
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62960604P | 2004-11-19 | 2004-11-19 | |
| PCT/US2005/040898 WO2006055412A1 (en) | 2004-11-19 | 2005-11-10 | Methods of treating erythropoietin-resistance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008520669A JP2008520669A (ja) | 2008-06-19 |
| JP2008520669A5 true JP2008520669A5 (enExample) | 2008-12-25 |
Family
ID=35809986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543135A Pending JP2008520669A (ja) | 2004-11-19 | 2005-11-10 | エリスロポエチン抵抗性を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060128805A1 (enExample) |
| EP (1) | EP1819334A1 (enExample) |
| JP (1) | JP2008520669A (enExample) |
| AU (1) | AU2005306772A1 (enExample) |
| CA (1) | CA2587558A1 (enExample) |
| WO (1) | WO2006055412A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083966A (en) | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
| WO2005034949A1 (en) | 2003-09-09 | 2005-04-21 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| PL1866296T3 (pl) | 2005-04-04 | 2017-05-31 | University Of Florida Research Foundation, Inc. | Polieterowe analogi desferritiocyny |
| CA2607953A1 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| WO2008015021A1 (en) * | 2006-08-04 | 2008-02-07 | Novartis Ag | Treatment of endocrine dysfunction using iron chelators |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| US20080132465A1 (en) * | 2006-12-05 | 2008-06-05 | Vincent Windisch | Apparatus and method for isolating iron components from serum |
| WO2008130395A2 (en) * | 2006-12-12 | 2008-10-30 | University Of Florida | Desferrithiocin analogue actinide decorporation agents |
| CA2680592C (en) | 2007-03-15 | 2016-07-05 | University Of Florida Research Foundation, Inc. | Desferrithiocin polyether analogues and uses thereof in treating pathological conditions |
| JPWO2010032489A1 (ja) | 2008-09-22 | 2012-02-09 | 国立大学法人旭川医科大学 | 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法 |
| US20120020974A1 (en) * | 2008-10-17 | 2012-01-26 | Beth Israel Deaconess Medical Center, Inc. | Optimizing erythropoietin therapy |
| JP5974233B2 (ja) * | 2008-11-12 | 2016-08-24 | リージェンメド（ケイマン）エルティーディー． | 単離した腎細胞およびその使用 |
| WO2011143292A1 (en) * | 2010-05-11 | 2011-11-17 | Ohio University | Biomarkers for detecting erythropoietin use in human subjects |
| CN103298466B (zh) | 2010-09-10 | 2015-11-25 | 武田制药美国有限公司 | 茶碱和非布索坦的联合治疗方法 |
| US9796605B2 (en) | 2011-01-14 | 2017-10-24 | Disease Adsorption System Technologies Co., Ltd. | Polymeric iron chelating agent |
| PT2688569T (pt) | 2011-03-21 | 2018-08-06 | Vivolux Ab | Tratamento de tumores sólidos |
| KR102111176B1 (ko) | 2011-12-16 | 2020-05-15 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 4'-데스페리티오신 유사체의 용도 |
| ES2734479T3 (es) | 2012-09-21 | 2019-12-10 | Vivolux Ab | Medios y métodos para tratar tumores sólidos |
| EP3071201A4 (en) | 2013-11-22 | 2017-04-26 | University of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
| US11517540B2 (en) | 2015-01-09 | 2022-12-06 | The Board Of Trustees Of The University Of Illinois | Restoring physiology in iron-deficient organisms using small molecules |
| KR20170140306A (ko) | 2015-04-27 | 2017-12-20 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8528983D0 (en) * | 1985-11-25 | 1986-01-02 | Ciba Geigy Ag | Use of chelating agents |
-
2005
- 2005-11-10 CA CA002587558A patent/CA2587558A1/en not_active Abandoned
- 2005-11-10 US US11/271,497 patent/US20060128805A1/en not_active Abandoned
- 2005-11-10 EP EP05825725A patent/EP1819334A1/en not_active Withdrawn
- 2005-11-10 AU AU2005306772A patent/AU2005306772A1/en not_active Abandoned
- 2005-11-10 WO PCT/US2005/040898 patent/WO2006055412A1/en not_active Ceased
- 2005-11-10 JP JP2007543135A patent/JP2008520669A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008520669A5 (enExample) | ||
| CN104869993B (zh) | 治疗阿尔茨海默病及相关疾病的组合疗法 | |
| Afshar et al. | Effects of intradialytic aerobic training on sleep quality in hemodialysis patients | |
| Kim et al. | The role of NF-κB signaling pathway in polyhexamethylene guanidine phosphate induced inflammatory response in mouse macrophage RAW264. 7 cells | |
| Herbertson et al. | Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. | |
| JP2010540657A5 (enExample) | ||
| JP2016513640A5 (enExample) | ||
| ATE339954T1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| JP2016520573A5 (enExample) | ||
| JP2009526754A5 (enExample) | ||
| WO2007006858A3 (en) | Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same | |
| HRP20141194T1 (hr) | Postupci lijeäśenja gihta | |
| JP2008500374A5 (enExample) | ||
| WO2006050155A3 (en) | Cancer therapeutic compositions | |
| JP2018531929A (ja) | Ｌ−オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも１つと組み合わせて用いる神経細胞喪失の治療および予防 | |
| JP2004517824A5 (enExample) | ||
| KR102205368B1 (ko) | Fxr 작용제의 신규 요법 | |
| Kim et al. | Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats | |
| JP2007119497A5 (enExample) | ||
| WO2001062799A3 (en) | Method for inhibiting angiogenesis using molecules that enhance plasmin activity | |
| EP1491210A4 (en) | THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES | |
| CN105456481A (zh) | 南五味子提取物在制备肝再生药物中的应用 | |
| CY1112440T1 (el) | Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3 | |
| Lee et al. | Long-term enteral arginine supplementation in rats with intestinal ischemia and reperfusion | |
| JP2011500650A5 (enExample) |